Large-scale testing (Phase 3)Study completedNCT04143217
What this trial is testing
Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD
Who this might be right for
Attention-Deficit/Hyperactivity Disorder
Supernus Pharmaceuticals, Inc. 159